Palo Alto Investors LP Karyopharm Therapeutics Inc. Transaction History

Palo Alto Investors LP

$501 Million
Q1 2025

A detailed history of Palo Alto Investors LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 324,032 shares of KPTI stock, worth $1.45 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

324,032

Previous 4,907,001 93.4%

Holding current value

$1.45 Million

Previous $3.34 Million 63.7%

% of portfolio

0.24%

Previous 0.53%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.6 - $9.83 $2.75 Million - $45.1 Million	-4,582,969 Reduced 93.4%	324,032 $1.21 Million
Q4 2024 Feb 14, 2025	SELL	$0.6 - $0.99 $117,115 - $193,240	-195,192 Reduced 3.83%	4,907,001 $3.34 Million
Q4 2023 Feb 14, 2024	SELL	$0.68 - $1.31 $390,104 - $751,524	-573,683 Reduced 10.11%	5,102,193 $4.39 Million
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $57,368 - $79,184	20,200 Added 0.36%	5,675,876 $22.1 Million
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $84,674 - $202,467	34,143 Added 0.61%	5,655,676 $19.2 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $892,888 - $2.17 Million	151,081 Added 2.76%	5,621,533 $41.4 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $455,354 - $752,514	87,400 Added 1.62%	5,470,452 $35.2 Million
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $157,334 - $215,534	19,400 Added 0.36%	5,383,052 $55.6 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $945,600 - $1.7 Million	96,000 Added 1.82%	5,363,652 $56.4 Million
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $2.57 Million - $3.12 Million	181,500 Added 3.57%	5,267,652 $81.5 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $12.3 Million - $17.1 Million	866,700 Added 20.54%	5,086,152 $74.3 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $1.34 Million - $2.03 Million	-80,449 Reduced 1.87%	4,219,452 $79.9 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $4.24 Million - $8.18 Million	-295,100 Reduced 6.42%	4,299,901 $82.6 Million
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $2.28 Million - $4.86 Million	-247,149 Reduced 5.1%	4,595,001 $88.1 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $2.38 Million - $4.98 Million	-420,113 Reduced 7.98%	4,842,150 $46.6 Million
Q1 2019 May 15, 2019	BUY	$4.12 - $10.25 $2.38 Million - $5.91 Million	576,911 Added 12.31%	5,262,263 $30.7 Million
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $180,629 - $373,374	22,028 Added 0.47%	4,685,352 $43.9 Million
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $11.8 Million - $19.5 Million	983,346 Added 26.72%	4,663,324 $79.2 Million
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $1.34 Million - $2.34 Million	135,539 Added 3.82%	3,679,978 $49.4 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $419,564 - $549,789	45,854 Added 1.31%	3,544,439 $34 Million
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $28.5 Million - $39 Million	3,498,585	3,498,585 $38.4 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

4.71M

Call Options Held

Put Options Held

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $358M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP Karyopharm Therapeutics Inc. Transaction History